Loading clinical trials...
Loading clinical trials...
Cytomegalovirus (CMV) infection was observed in over 30% of organ recipients with high morbidity. Moreover, no prophylaxis, 75% R + D-transplanted, 55%, R + D + and D-25% R + develop CMV. The number o...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
University Hospital, Limoges
NCT07090512 · Occurrence of Renal Dysfunction (GFR ≤ 60mL/(Min·1.73m2)) in Renal Transplant Recipients Within One Year After Kidney Transplantation
NCT03726307 · Kidney Transplant, Renal Transplant Recipients
NCT03504241 · Kidney Transplantation, Renal Transplantation, and more
NCT04218721 · Renal Transplant Recipients, Non-functioning Pituitary Adenoma
NCT02115503 · Renal Transplant Recipients With Anti-HLA Antibodies
Virologie
Besançon
Virologie
Caen
Virologie
Clermont-Ferrand
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions